Recessive myotonia congenita (Becker) Is genetically linked to HUMCLC, the gene encoding the muscular chloride channel, localized on chromosome 7q35. Three point mutations have so far been reported In HUMCLC, one causing recessive Becker-type myotonia, the others causing the clinically similar Thomsentype myotonia, which is Inherited as a dominant trait. We report a homozygous patient having a 4 base pair deletion in HUMCLC that shifts the reading frame and causes early stop codons, thus destroying the gene's coding potential for several membrane-spanning domains. In addition, we report a patient homozygous for a novel point mutation located at the extracellular side of the first membrane-spanning domain that causes removal of a negative charge (aspartlc acid-136-glyclne). Both mutations lead to the recessive type of myotonia congenita. Since the patient having the deletion presents less severe clinical myotonia than the patient carrying the missense mutation, it seems that the absence or truncation of the channel protein may disturb muscle fibre function less than the substitution of a single amlno acid.
INTRODUCTION
Recessive myotonia congenita (Becker) is a non-dystrophic disorder of the skeletal musculature, clinically characterized by stiffness and transient weakness that may occur in any skeletal muscle, in particular during voluntary movements that are initiated after a period of rest. The clinical symptom of myotonia in this disease is similar to the myotonia in the autosomal dominant disorder of myotonia congenita (Thomsen) , the first myotonic disease to be described (1) . The existence of a type of myotonia congenita with recessive inheritance was not recognized before the middle of this century (2) . Recessive myotonia is now registered as an entry of its own (MIM 255700) in McKusick's Mendelian Inheritance in Man (3) .
Electrophysiology (reviewed in ref. 4) has shown that the muscle stiffness in myotonia congenita is the result of repetitive electrical muscle fibre activity that may follow a brief stimulus. Such a stimulus may be activity of the motor nerve, electrical stimulation, or mechanical irritation, e.g. the movement of the electromyogram (EMG) needle or a blow with the neurological hammer (percussion myotonia). The mechanism causing the intrinsic muscle hyperexcitability underlying these 'myotonic runs' is based on a smaller than normal chloride conductance of the muscle fibre membrane. It was first discovered in an animal model, the myotonic goat (5), and later confirmed for both human Becker-and Thomsen-type myotonia (6 -8) .
In support of the electrophysiological data, genetic defects have been detected in HUMCLC, the gene encoding the skeletal muscle chloride channel, physically localized on chromosome 7q35 (9, 10) . Three point mutations of this gene have so far been reported. An unusual restriction site, seen in two Becker myotonia families, revealed a T-to-G transversion predicting a phenylalanine-413-cysteine substitution in the eighth of the putative 12 transmembrane domains (10) . Only in one family the patients were homozygous for this mutation. The mutations causing the dominant form are a glycine-230-glutamic acid substitution in the extracellular linker between the third and fourth domains (11) , and a proline-480-leucine substitution in the extracellular linker between the ninth and tenth domains of the channel protein (12) .
There are several animal models of recessive myotonia congenita, the most important being the ADR mouse (review: ref. 13 ). As in Becker-type myotonia, in this mutant, characterized by 'arrested development of righting response', the myotonia is caused by a much lower than normal chloride conductance of the skeletal muscle fibre membrane (14) . Before the genetic defects underlying human myotonia congenita were explored, it was already discovered that an insertion into the mouse muscle chloride channel gene destroys its coding potential for several membrane-spanning domains (15) .
It should be noted that at least two other genes are linked to myotonic diseases. Mutations of these genes cause myotonic symptoms by different pathomechanisms. (i) The expansion of a CTG repeat in the myotonic dystrophy gene, located on chromosome 19ql3.3 and encoding a protein kinase, leads to the multiple symptoms of myotonic dystrophy, including myotonia (recent review: ref. 16 ). (ii) Several point mutations in the gene encoding the a-subunit of the adult skeletal muscle sodium channel, located on chromosome 17q23-25, cause incomplete inactivation of the sodium channel, which may also lead to myotonia (review: ref. 17 ). Some of these mutations cause clinical symptoms that are very similar to those in autosomal dominant Thomsen-type myotonia congenita, in particular in myotonia fluctuans and myotonia permanens (18) (19) (20) (21) .
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The following results were obtained during a systematic search for mutations in HUMCLC in 16 German and 14 Turkish families having recessive myotonia congenita. All patients and family members entering the study gave informed consent to the clinical examination, the DNA investigation of their blood samples, and a muscle biopsy, when considered necessary. The study was approved by the Ethics Committee of the University of Ulm.
RESULTS
Investigating the skeletal muscle chloride channel DNA, we discovered an abnormality in the size of the polymerase chain reaction (PCR)-amplified DNA fragments of exon 12 of the HUMCLC transcript from the index patient of a Turkish family, RMC-43 (Fig. 1) . The fragments from both chromosomes had a smaller than normal size suggesting a deletion of several base pairs. The DNA fragments from both of his consanguineous parents and from his non-affected brother contained the same small product in addition to a product of normal size. By direct PCR sequencing of the amplified eluted DNA, we found in the abnormally sized fragments four bases (TTTG or TTGT or TGTT or GTTT) to be deleted from the sequence TTTGTTTG ( Fig.  2A ). This deletion alters the reading frame and thus generates several early stop codons, e.g. codons 433, 465, 488, 497, etc. ( Fig. 2B ; numbering according to the EMB Laboratory/GenBank database, accession number Z25587: K.Steinmeyer, C.Lorenz, M.Pusch, M.Koch and T.J.Jentsch. Multimeric structure of CLC-1 chloride channel revealed by mutations in dominant myotonia congenita Thomsen) . Therefore, it is likely that the result is a null mutation (complete loss-of-function) of the chloride channel.
Moreover, we detected a novel abnormal result in the pattern of the single-strand DNA fragments of exon 3 of the HUMCLC transcript for the index patient of the German family, RMC-7. In contrast to controls from normal subjects having two bands, his gel revealed only one band, suggesting a defective gene (not shown). By sequencing the amplified DNA eluted from this SSCA band and from the band of the non-denatured PCR product, we found an A-to-G transition at codon 136 of the cDNA that predicts a substitution of glycine for aspartic acid (Fig. 3) . The mobility of the mutant SSCA band was similar to that of the normal bands, so that heterozygous carriers of the gene defect were indistinguishable from controls with the naked eye. Therefore we performed an allele-specific oligonucleotide hybridization assay for PCR-amplified fragments of exon 3 of HUMCLC. Dotblots were made in duplicate and hybridized with either the normal or the mutant allele-specific probe (Fig. 4) . Using this technique we found that the patient was homozygous for the mutation whereas his mother and one of his brothers were heterozygous for the mutation, both clinically not affected. In addition, another heterozygous carrier of the A-to-G mutation was detected among 115 normal controls by use of this technique. Direct sequencing of the PCR products confirmed the heterozygous state in these three individuals (see example in Fig.  3 ). Direct sequencing of the PCR products of HUMCLC exons 1-12 of the RMC-7 patient and five normal controls yielded no additional changes in this portion of the HUMCLC sequence (approximately 30% of total coding sequence screened).
During the systematic search in our 30 families for mutations within the HUMCLC gene we found in four families the phenylalanine-to-cysteine substitution described by Koch et al. (10) . The patients were all heterozygous for the mutation. In addition, we detected in four Turkish families a C-to-T transition at position 1244 of the HUMCLC-encoding cDNA. This would cause an alanine-415-valine substitution at die end of the eighth transmembrane domain. In three of these families the patients were homozygous and their unaffected parents were heterozygous. Further research is needed to clarify whether this abnormality is a disease-causing mutation or just a common polymorphism in the Turkish population. In summary, including this C-to-G transition we found HUMCLC gene abnormalities in 10 of our 30 families, i.e. single-strand conformational polymorphism (SSCP) analysis of 
DISCUSSION
The deletion of 4 base pairs detected in the HUMCLC gene of the Turkish family may be regarded as the human equivalent to the ADR mouse mutation, since both mutations produce stop codons and thus destroy the coding potential of tie respective genes for the identical numbers of membrane-spanning domains (15) . Considering the general uncertainties associated with point mutations as to whether the predicted protein alteration really causes the clinical symptoms, a deletion introducing an early stop codon may be considered as proof for the linkage between myotonia and the muscle chloride channel gene. The reported deletion is situated in the highly conserved intracellular loop between the eighth and ninth membranespanning domains (Fig. 5) , not far from the known phenylalanine-413-cysteine mutation described for recessive myotonia congenita (10) .
The novel point mutation (aspartic acid-136-glycine) in both alleles of the German patient is located in a highly conserved DNA region coding for the extracellular side of the first membrane-spanning domain (Fig. 5) . It removes a negative charge and, as far as charge is concerned, has the opposite effect to the earlier reported mutation causing dominant myotonia congenita (Thomsen) , namely the glycine-230-glutamic acid substitution that introduces a negative charge in the adjacent extracellular linker between the third and fourth domains of the channel protein (11). mutant: Figure 4 . Pedigree of family RMC-7 and below its alkle-specific oligonucleotide hybridization assay foi PCR-amplified fragments of exon 3 of HUMCLC suggesting a homozygous mutation in the patient and a heterozygous in two family members. Duplicate dot-blots were probed with either the normal (codon GAC) or the mutant (codon GGC) allele-specific probe. The patient (filled square) revealed only the mutant DNA whereas his mother and a brother (both clinically non-affected) showed both the normal and the mutant DNA. The product of the other brother was the same as in a control. . In addition to the novel aspartic acid-to-glycine mutation, located at the extracellular side of the first membrane-spanning domain, and the deletion in the intracellular loop between the eighth and ninth domain, the drawing contains the point mutations reported so far for dominant (DMC; 11,12) and recessive (RMC; 10) myotonia congenita, and the insertion reported for the ADR mouse (22) .
As with sodium channel myotonias and other mutations in SCN4A (17), the various disease-causing point mutations in HUMCLC are not distributed over the gene in a predictable or easily understandable regular manner. They have in common that the mutant amino acids are not situated deep inside membranespanning parts of the channel protein. Rather, two of them (aspartic acid-136-glycine and glycine-23O-glutamic acid) are situated at the extracellular side of the membrane. The third mutation (phenylalanine-413-cysteine) is situated close to the sarcoplasmic face.
One would expect that the muscles of the patient having the deletion are without functional chloride channels. Since no other chloride channels except those encoded by HUMCLC are known to be expressed in adult skeletal muscle, the chloride conductance should be zero in this case. As the patient had already been biopsied at an earlier occasion, we were not allowed to biopsy him again just for the assessment of this parameter. The degree of his clinical myotonia was not unusually severe.
The myotonia of the patient carrying the missense mutation was more pronounced than that of the patient having the deletion. Therefore, the presence of a point-mutated protein may disturb muscle fibre function more than the presence of a truncated protein or its complete absence. An earlier electrophysiological in-vitro investigation of his muscle fibres had revealed that the chloride conductance was not zero, but 45/175 = 25% of control, i.e. 52% of the remaining total membrane conductance (8).
Thus for both patients, the molecular findings suggesting zero muscle chloride conductance, and the electrophysiological or clinical results disagree. Possibly there are alternative, so far not detected muscle chloride conductance pathways in skeletal muscle. Chloride channels different from HUMCLC have been described in human embryonic skeletal muscle (22) , but not in adult muscle. At any rate, the variance in severity of myotonia between different patients is not yet explained. As a well-known clinical fact, recessive myotonia is not really congenital (as is e.g. paramyotonia congenita). Rather, age of onset is usually in the second decade of life. The degree of clinical myotonia might depend also on factors other than the chloride conductance. Abnormalities in the behaviour of sodium channels have been reported for dominant myotonia congenita (23) .
Heterozygous carriers of the defective gene are clinically unaffected because the chloride channels expressed by the normal allele generate sufficient membrane conductance.
MATERIALS AND METHODS

Family RMC^U
The pedigree is shown in Fig. 1 . The only affected member is a 16-year-old boy who was noted to have muscle stiffness in his legs at the age of 2 when he had difficulty in walking and fell down frequently. As is typical with myotonia congenita, the gait problems were strongest after muscle rest and disappeared with continued walking. At age 4-5, the hands were noted to be involved. At age 11 -12, the patient became aware of difficulty when starting to chew or to speak. He complained of a sudden loss of strength when he lifted heavy objects. Sometimes he had to quit in the middle of a football game, when he developed a sudden weakness in the legs. The myotonia did not fluctuate, although there were days when he was slightly better. Pains were not a complaint. Hunger, emotion or fatigue did not affect the myotonia. He preferred cold environments. Alcohol improved the condition. The patient's parents were first cousins. There was no history of myotonia in the family.
The physical examination revealed muscle hypertrophy. There was bilateral limitation of wrist dorsiflexion and of left foot dorsiflexion. Percussion myotonia was demonstrated in the tongue, deltoid, biceps, extensor carpi radialis, abductor pollicis brevis and gastrocnemius. He had myotonia of the orbicularis oculi, masseter and hand muscles. Transient weakness was elicitable in the deltoid, biceps, triceps, interosseus, iliopsoas and possibly the tibialis anterior muscles The first contraction was usually normal, transient weakness appearing in the second to fourth contractions and full strength being reached with repeated contractions. Only the left interossei remained mildly weak. All other muscles had normal strength. The rest of the neurological examination was normal.
Laboratory findings. Creatine kinase and lactate dehydrogenase were normal. The EMG showed abundant myotonic discharges. On repetitive testing with 5 Hz (for 10 s) and 10 Hz (for 5 s), a marked decline of the compound muscle action potential was evident. Needle EMG was performed on the parents. The mother's EMG showed only slightly prolonged insertional activity. The father presented with a mild degree of myotonic discharges. Muscle biopsy showed mild fibre size variation and a slight increase in central nuclei.
Family RMC-7
The pedigree is shown in Fig. 4 . The only affected member is a 30-year old man. A specimen biopsied from his vastus medialis muscle had been electrophysiologically studied in vitro at a time when HUMCLC had not yet been cloned (8) .
The patient was noted to have generalized muscle stiffness already in early childhood. He was not able to walk before the age of 4 years. As an adult, he stumbled several times so severely that he became unconscious and amnestic. All of his muscles showed myotonia which was severe after rest, became better with repetitive movements (warm-up phenomenon), but never disappeared totally (stair case test 32 s after rest; and 5 s in the warmed-up state in contrast to < 3 s in normal controls). The lid-lag phenomenon was present and percussion myotonia was elicitable in almost all muscles. Slight generalized muscle hypertrophy was noted. The rest of the examination was normal. On slit-lamp examination, the patient had bilateral lens opacities in the posterior capsules, but the iridescent coloration typical for myotonic cataracts was not seen. A CT scan showed normal leg muscles. Creatine kinase was always normal. The EMG showed abundant myotonic discharges of short duration (up to 2 s) in all muscles. During voluntary force exertion, the EMG activity waned and waxed concordant with the transient weakness. Nerve conduction velocity and ECG were normal. The biopsy of the vastus medialis muscle revealed focal increase of central nuclei. The presence of prolonged CTG repeats in the myotonic dystrophy gene was excluded. Abnormal SSCPs were not found in any exon of SCN4A and all known SCN4A mutations (17) were excluded.
The family members did not show any symptoms or signs of myotonia. The mother's EMG was normal.
Molecular genetics
Genomk DNA was extracted from anticoagulated blood obtained from patients, their relatives and controls with informed consent.
PCR and gel dectrophoresls
Samples of genomic DNA were amplified by PCR with primers specific for the first 12 exons encoding the skeletal muscle chloride channel HUMCLC (10 min at 96°C, followed by 30 cycles of 94°C for 30 s, annealing temperature for 45 s, and 72°C for 1 min). Reaction mixtures with a final volume of 100 ill containing: 100 ng DNA, 50 pmol each PCR primer, 50 fiM each deoxynucleotide triphosphate, 10 mM Tris (pH 8.3), 50 mM KC1, 1.5 mM MgCI 2 , 1.5 units of AmpliTaq DNA polymerase. In particular, the primer sequences used for exon 3 were upstream 5' ttt tec etc ate tct tec ta, downstream 5' cca taa cac ace ctg en ac and for exon 12 were upstream 5' gac cac ctt ctg ctt ctt cc, downstream 5' tgg agg ttt agg gtg ttg ct. Five microlitres of the amplified samples were diluted with 1 u\ of gel loading dye (40% sucrose, 0.05% bromophenol blue, 0.05% xylene cyanol) and were loaded on 10% polyacrylamide gels. The gels were running at 300 V for 7-8 h in a buffer containing 90 mM Tris-borate (pH 8.3) and 2 mM EDTA. After electrophoresis the gels were stained with 0.5 ethidium bromide. SSCA was performed as reported (11) .
Direct PCR sequencing
Single bands were cut directly from the gels under UV light and placed for 15 min in 100 jd of distilled water at 80°C. A 10 iii aliquot was used for asymmetric PCR re-amplification with the same PCR primers and conditions except of the primer ratio (5 -50 pmol) and amplification was carried out for 50 cycles. PCR products were purified with centricon-100 dialysis concentrators (Amicon) and 30-50% of the retentate was sequenced with the dideoxy termination method using Taq polymerase, upstream or downstream primers, and fluorescemly tagged dideoxynucleoside triphosphates on a 373 DNA sequencer (Applied Biosystems, Foster City, CA).
Allele-spectflc ollgonucleotlde hybridization
Oligonucleotide (lSmer) was synthesized to match the sequence of either the normal or the disease mutant (exon 3): normal allele, 5' cat gga eta cgt cag tgc; mutant allele, 5' cat ggg eta cgt cag tgc. After amplification of genomic DNA with exon 3 primers, 10 jil aliquots were heat denatured, applied to positive charged nylon membrane using a dot blot apparatus. Duplicate membranes were prepared, dried at 120°C for 15 min and prehybridized in 5xSSC, 1% blocking reagent (Boehringer, Mannheim, Germany), 0.1 % N-laurorylesarcosine and 0.5% sodiumdodecyl sulphate (SDS). Allde-specific probes were end-labelled using digoxigenindUTP and terminal transferase (Boehringer, Mannheim). Hybridizations were performed at either 53°C (normal) or 59°C (mutant) for 2 h with 10 pmol of tailed oligonucleotide. Filters were washed twice with 2xSSC/0.1% SDS and 0.1 xSSC/0.1% SDS at hybridization temperature. The hybrids were detected by enzyme-linked immunoassay using anndigoxigenin-alkaline phosphate conjugate and subsequent enzyme-catalysed colour reaction with 54)rorno-4-chloro-3-indolyl phosphate and nitro blue tetrazolium salt (Boehringer, Mannheim).
